Immunovant Short Long Term Debt vs Net Invested Capital Analysis

IMVT Stock  USD 28.73  1.57  5.78%   
Immunovant financial indicator trend analysis is infinitely more than just investigating Immunovant recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunovant is a good investment. Please check the relationship between Immunovant Short Long Term Debt and its Net Invested Capital accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunovant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Immunovant Stock please use our How to Invest in Immunovant guide.

Short Long Term Debt vs Net Invested Capital

Short Long Term Debt vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunovant Short Long Term Debt account and Net Invested Capital. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Immunovant's Short Long Term Debt and Net Invested Capital is -0.51. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Immunovant, assuming nothing else is changed. The correlation between historical values of Immunovant's Short Long Term Debt and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Immunovant are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Short Long Term Debt i.e., Immunovant's Short Long Term Debt and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

-0.51
Relationship DirectionNegative 
Relationship StrengthVery Weak

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.
Most indicators from Immunovant's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunovant current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunovant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Immunovant Stock please use our How to Invest in Immunovant guide.At this time, Immunovant's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 496.4 M in 2024, despite the fact that Enterprise Value Multiple is likely to grow to (5.03).
 2021 2022 2023 2024 (projected)
Total Operating Expenses156.0M208.3M282.7M150.5M
Research Development101.8M160.3M212.9M118.3M

Immunovant fundamental ratios Correlations

0.91.00.910.630.920.980.911.00.280.890.62-0.94-1.0-0.950.960.60.830.960.430.93-0.030.920.81-0.890.96
0.90.90.940.690.980.891.00.90.350.970.61-0.91-0.92-0.880.950.590.90.950.490.980.050.980.88-0.880.95
1.00.90.90.620.920.980.91.00.280.880.62-0.94-1.0-0.950.960.60.820.960.430.93-0.030.920.8-0.880.96
0.910.940.90.70.970.840.950.910.520.880.83-0.98-0.92-0.790.970.820.910.970.460.970.030.970.78-0.90.97
0.630.690.620.70.610.540.690.630.30.510.56-0.62-0.64-0.480.680.550.540.680.950.61-0.050.620.28-0.530.67
0.920.980.920.970.610.90.980.920.40.970.69-0.96-0.94-0.880.980.670.920.980.371.00.041.00.9-0.910.98
0.980.890.980.840.540.90.890.980.150.910.49-0.89-0.98-0.990.920.460.780.920.360.9-0.060.90.85-0.850.92
0.911.00.90.950.690.980.890.910.370.970.63-0.92-0.92-0.880.960.620.910.960.490.980.050.990.88-0.890.96
1.00.91.00.910.630.920.980.910.270.890.61-0.94-1.0-0.950.960.590.830.960.430.93-0.030.920.81-0.890.96
0.280.350.280.520.30.40.150.370.270.290.72-0.45-0.29-0.050.380.750.660.380.140.440.670.360.15-0.630.37
0.890.970.880.880.510.970.910.970.890.290.51-0.89-0.9-0.920.920.50.890.920.290.960.080.970.96-0.880.92
0.620.610.620.830.560.690.490.630.610.720.51-0.82-0.64-0.380.711.00.680.710.30.70.00.680.4-0.680.71
-0.94-0.91-0.94-0.98-0.62-0.96-0.89-0.92-0.94-0.45-0.89-0.820.950.84-0.96-0.8-0.87-0.96-0.36-0.960.05-0.95-0.810.9-0.96
-1.0-0.92-1.0-0.92-0.64-0.94-0.98-0.92-1.0-0.29-0.9-0.640.950.94-0.97-0.62-0.84-0.97-0.44-0.940.03-0.94-0.810.89-0.97
-0.95-0.88-0.95-0.79-0.48-0.88-0.99-0.88-0.95-0.05-0.92-0.380.840.94-0.89-0.36-0.75-0.89-0.31-0.880.08-0.89-0.90.8-0.89
0.960.950.960.970.680.980.920.960.960.380.920.71-0.96-0.97-0.890.690.91.00.460.980.00.980.83-0.891.0
0.60.590.60.820.550.670.460.620.590.750.51.0-0.8-0.62-0.360.690.690.690.30.690.040.660.39-0.680.69
0.830.90.820.910.540.920.780.910.830.660.890.68-0.87-0.84-0.750.90.690.90.320.940.40.90.8-0.970.9
0.960.950.960.970.680.980.920.960.960.380.920.71-0.96-0.97-0.891.00.690.90.460.980.00.980.83-0.891.0
0.430.490.430.460.950.370.360.490.430.140.290.3-0.36-0.44-0.310.460.30.320.460.37-0.030.390.06-0.320.45
0.930.980.930.970.611.00.90.980.930.440.960.7-0.96-0.94-0.880.980.690.940.980.370.090.990.89-0.930.98
-0.030.05-0.030.03-0.050.04-0.060.05-0.030.670.080.00.050.030.080.00.040.40.0-0.030.09-0.010.0-0.38-0.01
0.920.980.920.970.621.00.90.990.920.360.970.68-0.95-0.94-0.890.980.660.90.980.390.99-0.010.91-0.880.98
0.810.880.80.780.280.90.850.880.810.150.960.4-0.81-0.81-0.90.830.390.80.830.060.890.00.91-0.780.83
-0.89-0.88-0.88-0.9-0.53-0.91-0.85-0.89-0.89-0.63-0.88-0.680.90.890.8-0.89-0.68-0.97-0.89-0.32-0.93-0.38-0.88-0.78-0.89
0.960.950.960.970.670.980.920.960.960.370.920.71-0.96-0.97-0.891.00.690.91.00.450.98-0.010.980.83-0.89
Click cells to compare fundamentals

Immunovant Account Relationship Matchups

Immunovant fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets109.4M412.5M515.6M405.8M666.4M699.7M
Total Current Liabilities15.3M18.8M44.5M43.3M48.6M27.1M
Total Stockholder Equity94.1M391.5M469.8M362.5M617.8M648.6M
Net Tangible Assets94.1M391.5M469.8M362.5M416.9M242.7M
Accounts Payable1.2M2.4M18.6M1.4M7.2M5.0M
Common Stock Shares Outstanding43.2M87.8M109.7M123.1M138.1M80.8M
Other Stockholder Equity185.3M590.4M824.8M928.0M1.4B1.5B
Total Liab15.3M21.0M45.7M43.3M48.6M27.7M
Total Current Assets109.1M409.0M512.9M404.3M665.8M699.1M
Short Long Term Debt Total3.2M3.4M2.4M1.2M138K131.1K
Other Current Liab14.1M14.0M24.7M40.8M41.2M24.7M
Property Plant And Equipment Net65K3.5M2.6M1.5M595K565.3K
Net Debt(97.4M)(396.7M)(491.5M)(375.3M)(635.2M)(603.5M)
Retained Earnings(91.2M)(198.7M)(355.4M)(566.3M)(825.7M)(784.4M)
Cash100.6M400.1M493.8M376.5M635.4M367.9M
Non Current Assets Total311K3.5M2.6M1.5M595K565.3K
Cash And Short Term Investments100.6M400.1M493.8M376.5M635.4M367.9M
Net Receivables3.0M1.1M12.9M885K5.5M4.8M
Common Stock Total Equity5K10K12K13K15.0K8.9K
Liabilities And Stockholders Equity109.4M412.5M515.6M405.8M666.4M386.8M
Non Current Liabilities Total14.1M2.2M1.2M47K347K329.7K
Capital Surpluse185.3M590.4M824.8M928.0M1.1B556.3M
Other Current Assets5.5M7.7M6.3M26.9M24.9M13.1M
Net Invested Capital94.1M391.5M469.8M362.5M617.8M354.9M
Capital Stock5K10K12K13K14K10.0K
Net Working Capital93.8M390.2M468.4M361.0M617.2M353.9M
Short Term Debt3.2M2.4M1.1M1.2M276K262.2K
Common Stock5K10K12K13K14K10.0K
Property Plant Equipment65K201K330K333K383.0K216.3K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Immunovant Stock Analysis

When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.